+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use and risk of gastroduodenal ulcer and reflux esophagitis

Statin use and risk of gastroduodenal ulcer and reflux esophagitis

Hepato-Gastroenterology 56(91-92): 641-644

Several trials have demonstrated beneficial effects of statins in some biological activities that go beyond lipid lowering, suggesting that statins might have other therapeutic benefits. However, it remains to be determined whether statin use is correlated with upper gastrointestinal diseases. We investigated the effects of statin therapy on gastroduodenal ulcers or reflux esophagitis (RE) in a case-control study. We identified 120 newly diagnosed gastroduodenal ulcer cases and 146 RE cases from endoscopic examinees in the Gunma Prefectural Cardiovascular Center. Two controls per case were respectively selected according to sex and age and we determined 240 and 292 controls. We calculated odds ratios (OR) and 95% confidence intervals (CI) of peptic ulcer and RE for statin use. Statin use was not associated with the risk of peptic ulcer (OR 1.2; 95% CI 0.7-2.1), and no elevated OR of RE was shown (OR 0.8; 95%CI 0.5-1.4). Ever use of hydrophilic statins, or lipophilic statins was not associated with the risk of peptic ulcer or RE. Our results suggest that statin use might not be associated with peptic ulcer or RE. These findings indicate that statin therapy might be safe for patients with upper gastrointestinal disease.

(PDF emailed within 1 workday: $29.90)

Accession: 055911432

Download citation: RISBibTeXText

PMID: 19621671

Related references

The relationship of gastroduodenal reflex with the frequency of gastric ulcer and reflux esophagitis. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1266, April, 2000

Duodenal ulcer disease, gastroduodenal motor function and reflux esophagitis--a cross-sectional survey in a subset of Taiwanese patients. Neurogastroenterology and Motility 23(9): 840-845, 2011

No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. Plos One 8(6): E65996-E65996, 2014

Gastroesophageal reflux and reflux esophagitis in young people with gastroduodenal diseases. Vutreshni Bolesti 25(5): 36-38, 1986

Eradication of Helicobacter pylori was not a risk factor for reflux esophagitis in Japanese patients with peptic ulcer. Gut 51(Supplement 2): A67, September, 2002

Clinical relevance of gastroduodenal dysfunction in reflux esophagitis. Journal of Clinical Gastroenterology 8 Suppl 1: 17-25, 1986

State of the gastroduodenal system in patients with reflux esophagitis. Klinicheskaia Meditsina 66(7): 88-90, 1988

Pathology and histology of the ulcer including barrets ulcer reflux esophagitis and gastroduodenitis. Lesch, P And R Haering Ulkus: Diagnostik Und Therapie; (Ulcers: Diagnosis And Treatment) 490p Tm-Verlag: Hameln, Germany Illus 31-62, 1990

Prevalence of reflux esophagitis in patients with duodenal ulcer and gastric ulcer. Journal of Gastroenterology 38(5): 514-515, 2003

Peptic esophagitis and gastroduodenal ulcer. Rassegna Clinico-Scientifica 29(11): 326-329, 1953

Vagotomy in the treatment of bleeding reflux-esophagitis and gastroduodenal bleedings. Khirurgiia: 24-26, 2004

Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study. Indian Journal of Gastroenterology 5 Suppl: 29-33, 1986

Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats. Journal of Gastroenterology 41(3): 198-208, 2006

Long-term clinical course of ulcer disease and incidence of reflux esophagitis in a large cohort of duodenal ulcer patients followed after eradication of Helicobacter pylori. Gut 37(SUPPL 1): A6, 1995